Reduced adherence to antiretroviral therapy among HIV-infected tanzanians seeking cure from the loliondo healer

Journal of Acquired Immune Deficiency Syndromes

Volumn 65, Issue 3, 2014, Pages

  Thielman, Nathan M ^a,b,c   Ostermann, Jan ^a,b   Whetten, Kathryn ^a,b   Whetten, Rachel ^a   Itemba, Dafrosa ^d   Maro, Venance ^c   Pence, Brian ^a,b,e   Reddy, Elizabeth ^b,c  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d Tanzania Women's Research Foundation (TAWREF)   (Tanzania)

^e KILIMANJARO CHRISTIAN MEDICAL CENTRE   (Tanzania)

Author keywords

adherence; Africa; antiretroviral therapy; faith healing; Global Health; HIV AIDS; traditional healing

Indexed keywords

AFRICA; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FAITH HEALING; HIV INFECTIONS; HUMANS; MEDICATION ADHERENCE; TANZANIA;

EID: 84894479091     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/01.qai.0000437619.23031.83     Document Type: Conference Paper

References (35)

1. World Health Organization. Global HIV/AIDS Response Epidemic Update and Health Sector Progress Towards Universal Access: Progress Report 2011. Geneva Switzerland: World Health Organization; 2011
2. Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: A meta-Analysis. JAMA. 2006; 296:679-690
3. Nachega JB, Hislop M, Nguyen H, et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J Acquir Immune Defic Syndr. 2009;51:65-71
4. Orrell C, Bangsberg DR, Badri M, et al. Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS. 2003;17: 1369-1375
5. Unge C, Södergård B, Ekström AM, et al. Challenges for scaling up ART in a resource-limited setting: A retrospective study in Kibera, Kenya. J Acquir Immune Defic Syndr. 2009;50:397-402
6. Byakika-Tusiime J, Crane J, Oyugi JH, et al. Longitudinal antiretroviral adherence in HIV+ Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: Role of depression in declining adherence over time. AIDS Behav. 2009;13(suppl 1): 182-191
7. Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: Systematic review. Trop Med Int Health. 2010;15(suppl 1):11-15
8. Mannheimer SB, Matts J, Telzak E, et al. Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care. 2005;17:10-22
9. Lanièce I, Ciss M, Desclaux A, et al. Adherence to HAART and its principal determinants in a cohort of Senegalese adults. AIDS. 2003;17 (suppl 3):S103-S108
10. Byakika-Tusiime J, Oyugi JH, Tumwikirize WA, et al. Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy. Int J STD AIDS. 2005;16:38-41
11. Ramadhani HO, Thielman NM, Landman KZ, et al. Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania. Clin Infect Dis. 2007;45:1492-1498
12. Ware NC, Idoko J, Kaaya S, et al. Explaining adherence success in sub-Saharan Africa: An ethnographic study. PLoS Med. 2009;6:e11
13. Charurat M, Oyegunle M, Benjamin R, et al. Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: A longitudinal analysis for risk factors. PLoS One. 2010;5:e10584
14. Hardon AP, Akurut D, Comoro C, et al. Hunger, waiting time and transport costs: Time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19:658-665
15. Tuller DM, Bangsberg DR, Senkungu J, et al. Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: A qualitative study. AIDS Behav. 2010; 14:778-784
16. Rachlis BS, Mills EJ, Cole DC. Livelihood security and adherence to antiretroviral therapy in low and middle income settings: A systematic review. PLoS One. 2011;6:e18948
17. Birbeck GL, Chomba E, Kvalsund M, et al. Antiretroviral adherence in rural Zambia: The first year of treatment availability. Am J Trop Med Hyg. 2009;80:669-674
18. Do NT, Phiri K, Bussmann H, et al. Psychosocial factors affecting medication adherence among HIV-1 infected adults receiving combination antiretroviral therapy (cART) in Botswana. AIDS Res Hum Retroviruses. 2010;26:685-691
19. Bajunirwe F, Arts EJ, Tisch DJ, et al. Adherence and treatment response among HIV-1-infected adults receiving antiretroviral therapy in a rural government hospital in Southwestern Uganda. J Int Assoc Physicians AIDS Care (Chic). 2009;8:139-147
20. Amberbir A, Woldemichael K, Getachew S, et al. Predictors of adherence to antiretroviral therapy among HIV-infected persons: A prospective study in Southwest Ethiopia. BMC Public Health. 2008;8:265
21. Nakimuli-Mpungu E, Bass JK, Alexandre P, et al. Depression, Alcohol Use and adherence to antiretroviral therapy in sub-Saharan Africa: A systematic review. AIDS Behav. 2012;16:2101-2118
22. Etienne M, Hossain M, Redfield R, et al. Indicators of adherence to antiretroviral therapy treatment among HIV/AIDS patients in 5 African countries. J Int Assoc Physicians AIDS Care (Chic). 2010;9:98-103
23. Dahab M, Charalambous S, Karstaedt AS, et al. Contrasting predictors of poor antiretroviral therapy outcomes in two South African HIV programmes: A cohort study. BMC Public Health. 2010;10:430
24. Wanyama J, Castelnuovo B, Wandera B, et al. Belief in divine healing can be a barrier to antiretroviral therapy adherence in Uganda. AIDS. 2007;21:1486-1487
25. Eholié SP, Tanon A, Polneau S, et al. Field adherence to highly active antiretroviral therapy in HIV-infected adults in Abidjan, Côte dIvoire. J Acquir Immune Defic Syndr. 2007;45:355-358
26. Roura M, Busza J, Wringe A, et al. Barriers to sustaining antiretroviral treatment in Kisesa, Tanzania: A follow-up study to understand attrition from the antiretroviral program. AIDS Patient Care STDS. 2009;23: 203-210
27. Musheke M, Bond V, Merten S. Individual and contextual factors influencing patient attrition from antiretroviral therapy care in an urban community of Lusaka, Zambia. J Int AIDS Soc. 2012;15(suppl 1):11-19
28. Malebo HM, Mbwambo ZH. Technical Report on Miracle Cure Prescribed by Rev. Ambilikile Mwasupile. Dar es Salaam, Tanzania: National Institute for Medical Research and Institute of Traditional Medicine; 2011
29. Ashforth A. AIDS, religious enthusiasm and spiritual insecurity in Africa. Glob Public Health. 2011;6(suppl 2):S132-S147
30. Pence BW, Shirey K, Whetten KA, et al. Prevalence of psychological trauma and association with current health and functioning in a sample of HIV-infected and HIV-uninfected Tanzanian adults. PLoS One. 2012;7: E36304
31. Koenig HG, Büssing A. The Duke University Religion Index (DUREL): A five-item measure for use in epidemological studies. Religions. 2010;1: 78-85
32. Zou J, Yamanaka Y, John M, et al. Religion and HIV in Tanzania: Influence of religious beliefs on HIV stigma, disclosure, and treatment attitudes. BMC Public Health. 2009;9:75
33. Kisenyi R,Muliira J, Ayebare E. Religiosity and adherence to antiretroviral therapy among patients attending a public hospital-Based HIV/AIDS clinic in Uganda. J Relig Health. 2013;52:307-317
34. Namuddu B, Kalyango JN, Karamagi C, et al. Prevalence and factors associated with traditional herbal medicine use among patients on highly active antiretroviral therapy in Uganda. BMC Public Health. 2011;11:855
35. Curlin FA, Chin MH, Sellergren SA, et al. The association of physicians religious characteristics with their attitudes and self-reported behaviors regarding religion and spirituality in the clinical encounter. Med Care. 2006;44:446-453